In a perfect democracy, at least 50% of people would support every decision.

The U.S. falls short of this goal.

Activate to continue

Spoken For.
House vote: S. 204 // May 22, 2018

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

Sponsor: Ron Johnson (R-WI)

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to exempt, from specified requirements and restrictions under that Act and other laws, the provision of certain unapproved, investigational drugs to a terminally ill patient who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs. The manufacturer or sponsor of an eligible investigational drug must report annually to the Food and Drug Administration (FDA) on any use of the drug in accordance with these provisions.

Health Topic assigned by the Congressional Research Service.

Who won, and how much of the country was behind them

Won the vote · Yea

250 votes, representing 145,427,606 people57.4%of U.S. adults

Lost the vote · Nay

169 votes, representing 98,700,247 people39.0%of U.S. adults

The dotted gap is 3.6% of U.S. adults whose member did not vote, voted “present,” or whose seat was vacant.

Share of U.S. adults represented, the House
SideOutcomeVotesShare of U.S. adults
YeaWon25057.4%
NayLost16939.0%
Not represented on this questionNo position taken03.6%